Avelas Biosciences

San Diego, United States · Founded 2008 · $41.9M raised

Employees
11–50
Founded
2008
Total Funding
$41.9M
Last Round
$20.0M Series CMar 2017
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Avelas Biosciences is a San Diego biotechnology company developing fluorescence-guided imaging technology to improve cancer surgery. Founded in 2008 by Avalon Ventures around science from Nobel laureate Roger Tsien, Avelas created a real-time tumor-visualization agent designed to help surgeons distinguish cancerous from healthy tissue during operations, aiming to reduce repeat surgeries and improve outcomes. The company has advanced its lead candidate through clinical development backed by Series B and Series C financings.

Summary

Avelas Biosciences is a Biotech company based in San Diego, United States, founded in 2008. It has raised $41.9M in total across 4 rounds, most recently a $20.0M Series C round in Mar 2017. Investors include Avalon Ventures, Pharmstandard and Torrey Pines Investment.

Funding History

Series CSeries CMar 2017
$20.0M

Sign up to see all 4 events

Funding: Series A through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Avelas Biosciences on Indexed.vc
<a href="https://indexed.vc/companies/avelas-biosciences"><img src="https://indexed.vc/api/badge/company/avelas-biosciences" alt="Avelas Biosciences on Indexed.vc" width="260" height="76" /></a>